{"task_id": "cfdd7cc3c28c0ff3", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 231/464)", "text": "nths for at least 3 years if the\n220\nTumor Markers\n\n--- Page 242 ---\nCARCINOEMBRYONIC ANTIGEN (CEA) (CONT\u2019D)\npatient is a potential candidate for surgery or\nchemotherapy for metastatic disease (even if pre\nviously CEA negative)\n\u0002\nMETASTATIC SETTING\nCEA is the marker of choice\nfor monitoring the response of metastatic disease\nto systemic therapy\nCA 19 9\nNORMAL RANGE\n<37 kU/L\nELEVATED\npancreatic cancer (sens 70 90%, spc\n80 90%),\ncholangiocarcinoma,\ncolorectal\ncancer\n(sens 20 40%), gastric cancer (sens 20 40%), ovarian\ncancer, pancreatitis, liver failure\nUTILITY IN PANCREATIC CANCER\n\u0002\nDIAGNOSIS\nlevel\n>120 kU/L\nis\nsuggestive\nof\nmalignancy. Level >1000 kU/L predicts metastatic\ndisease (PPV of 97%)\n\u0002\nRESECTABLE DISEASE\nelevated CA19 9 postopera\ntively may predict for recurrent disease\n\u0002\nLOCALLY ADVANCED OR METASTATIC DISEASE\neleva\ntions in serial CA 19 9 suggest progressive disease\nbut confirmation with other studies needed\nCA 15 3\nNORMAL RANGE\n<28 kU/L\nELEVATED\nbreast cancer (sens for stage I 5 30%, stage\nII 15 50%, stage III 60 70%, stage IV 65 90%), ovarian\ncancer (46%), lung cancer (26%), liver cancer (30%)\nUTILITY IN BREAST CANCER\n\u0002\nDIAGNOSIS\nmay be used sometimes to determine\nthe presence of metastatic disease. 86 kU/L + his\ntory of breast cancer strongly suggests metastasis\n\u0002\nMETASTATIC\nSETTING\nmay be used to suggest\ntreatment failure, particularly if disease is not read\nily measurable\nCA 125\nNORMAL RANGE\n<35 kU/L\nCA 125 (CONT\u2019D)\nELEVATED\nepithelial ovarian cancer (sens 50%\nin stage I, 85% in all), breast cancer, colorectal cancer,\npancreatic cancer, lung cancer, endometrial cancer,\nbenign ovarian tumors (sens 26%), ascites, peritonitis,\npelvic inflammatory disease, cirrhosis, menstruation,\nendometriosis, salpingitis, fibroids, right sided heart\nfailure, first trimester pregnancy\nUTILITY IN EPITHELIAL OVARIAN CANCER\n\u0002\nSCREENING\nmay have a role in early detection of\novarian cancer in women with hereditary ovarian\ncancer syndrome in combination with transvaginal\nultrasound\n\u0002\nDIAGNOSIS\nin\npostmenopausal\nwomen\nwith\nasymptomatic palpable pelvic masses, CA 125\n>65 kU/L has PPV of 90% for ovarian cancer\n\u0002\nPROGNOSIS\nrate of decrease in CA 125 after cytor\neductive surgery and during cytotoxic chemother\napy has prognostic value\n\u0002\nRESPONSE\nuseful for following disease response\nduring cytotoxic chemotherapy\n\u0002\nADJUVANT SETTING\nevery 3 months for 2 years.\nHowever, limited treatment for relapsed disease\nlimits clinical value of detection\nTUMOR MARKERS IN EVERYDAY PRACTICE\nTumor type\nTumor marker\nProstate\nPSA\nColorectal (GI)\nCEA, CA 19 9\nPancreas\nCA 19 9, CEA\nLiver\naFP\nBreast\nCA 15 3, CEA, CA 125, CA 27.29\nOvary\nCA 125, CA 15 3, CA 19 9, CEA\nLung\nCEA, CA 19 9, CA 125, LDH\nGerm cell tumor\naFP, bhCG, LDH\nGTN\nbhCG\nCarcinoid tumor\nChromogranin, 5 HIAA\nNon Hodgkin\u2019s\nLDH\nHodgkin\u2019s\nALP\nMyeloma\nM protein, b2 microglobulin\nUTILITY OF SPECIFIC TUMOR MARKERS\nTumor marker\nTumor type\nScreen\nDiagnosis\nPrognosis\nResponse\nFollow up (recurrence)\nPSA\nProstate\np?\np\np\np\np\nCEA\nColorectal\n\u0003\n\u0003\np\np\np\nCA 19 9\nPancreas\n\u0003\n\u0003?\n\u0003\np?\np?\nCA 15 3\nBreast\n\u0003\n\u0003\n\u0003\nM\nx\nCA 125\nOvary\n\u0003?\nx?\np\np\np?\naFP\nGerm cell\n\u0003\np\np\np\np\nLiver\n\u0003?\np\np\np\n\u0003\nbhCG\nGerm cell\n\u0003\np\np\np\np\nGTN\n\u0003\np\np\np\np\nLDH\nGerm cell\n\u0003\np\np\np\np\nLymphoma\n\u0003\n\u0003\np\np\n\u0003\np=useful, ?=controversial, x=not useful, M=metastatic setting only\n221\nTumor Markers", "text_length": 3305, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 231/464)", "type": "chunk", "chunk_index": 230, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.564978", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.565712", "status": "complete", "chunks_added": 2}